HEOR Theater - Demonstrating the Value of Vaccines: Global NITAG and HTA Requirements

November 18, 2021

Open to all ISPOR Members and Non-members

Presented by

  • Claire Chadwick
  • Marie Chivers
  • Vanya Nikolova

November 18, 2021
12:00PM EST | 5:00PM GMT | 6:00PM CET 

Click here for time zone conversion

Since 2020, vaccine development and evidence-based evaluation by national immunization technical advisory groups (NITAGs) and health technology assessment (HTA) agencies have become important line items in pharmaceutical investment and strategic planning. Now more than ever, HEOR and market access teams need to ensure they have a deep understanding of vaccine evaluation requirements to plan for success. During this presentation we will analyze the global requirements of NITAGs and HTA agencies for vaccine evaluation, and discuss how you can provide your team with the materials they need to demonstrate value.

Learning Objectives:

  • Understand which stakeholders are involved in vaccine evaluation, and global NITAG and HTA requirements. 
  • Consider differences in vaccine modeling requirements among markets
  • Explore how to develop global value dossiers that meet the needs of NITAGs and HTA agencies.

Register Here 

Sponsored by: PRMA Consulting


Claire Chadwick, Associate Director, PRMA Consulting

Marie Chivers, Senior Consultant, PRMA Consulting

Vanya Nikolova, Consultant, PRMA Consulting

Please note: On the day of the scheduled HEOR Theater, the first 1000 registered participants will be accepted. For those who are unable to attend, or would like to review the HEOR Theater On-Demand at a later date, please register using the link above to access the full-length recording. 

Reservations are on a first-come, first-served basis.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now